168 related articles for article (PubMed ID: 26576034)
1. KIAA2022 nonsense mutation in a symptomatic female.
Farach LS; Northrup H
Am J Med Genet A; 2016 Mar; 170(3):703-6. PubMed ID: 26576034
[TBL] [Abstract][Full Text] [Related]
2. De novo mutations of KIAA2022 in females cause intellectual disability and intractable epilepsy.
de Lange IM; Helbig KL; Weckhuysen S; Møller RS; Velinov M; Dolzhanskaya N; Marsh E; Helbig I; Devinsky O; Tang S; Mefford HC; Myers CT; van Paesschen W; Striano P; van Gassen K; van Kempen M; de Kovel CG; Piard J; Minassian BA; Nezarati MM; Pessoa A; Jacquette A; Maher B; Balestrini S; Sisodiya S; Warde MT; De St Martin A; Chelly J; ; van 't Slot R; Van Maldergem L; Brilstra EH; Koeleman BP
J Med Genet; 2016 Dec; 53(12):850-858. PubMed ID: 27358180
[TBL] [Abstract][Full Text] [Related]
3. De novo loss of function mutations in KIAA2022 are associated with epilepsy and neurodevelopmental delay in females.
Webster R; Cho MT; Retterer K; Millan F; Nowak C; Douglas J; Ahmad A; Raymond GV; Johnson MR; Pujol A; Begtrup A; McKnight D; Devinsky O; Chung WK
Clin Genet; 2017 May; 91(5):756-763. PubMed ID: 27568816
[TBL] [Abstract][Full Text] [Related]
4. Delineation of the KIAA2022 mutation phenotype: two patients with X-linked intellectual disability and distinctive features.
Kuroda Y; Ohashi I; Naruto T; Ida K; Enomoto Y; Saito T; Nagai J; Wada T; Kurosawa K
Am J Med Genet A; 2015 Jun; 167(6):1349-53. PubMed ID: 25900396
[TBL] [Abstract][Full Text] [Related]
5. Two novel EIF2S3 mutations associated with syndromic intellectual disability with severe microcephaly, growth retardation, and epilepsy.
Moortgat S; Désir J; Benoit V; Boulanger S; Pendeville H; Nassogne MC; Lederer D; Maystadt I
Am J Med Genet A; 2016 Nov; 170(11):2927-2933. PubMed ID: 27333055
[TBL] [Abstract][Full Text] [Related]
6. Clinical spectrum of KIAA2022/NEXMIF pathogenic variants in males and females: Report of three patients from Indian kindred with a review of published patients.
Panda PK; Sharawat IK; Joshi K; Dawman L; Bolia R
Brain Dev; 2020 Oct; 42(9):646-654. PubMed ID: 32600841
[TBL] [Abstract][Full Text] [Related]
7. [Epilepsy and other phenotypic features of X-linked intellectual disability caused by the mutations in the KIAA2022 gene].
Gamirova RG; Barkov AI; Shaimuchametova VA; Liukshina NG; Volkov IV; Tomenko TR; Rachmanina OA; Shestakova OI; Gorobets EA
Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(9. Vyp. 2):14-20. PubMed ID: 36170093
[TBL] [Abstract][Full Text] [Related]
8. Novel NEXMIF pathogenic variant in a boy with severe autistic features, intellectual disability, and epilepsy, and his mildly affected mother.
Lambert N; Dauve C; Ranza E; Makrythanasis P; Santoni F; Sloan-Béna F; Gimelli S; Blouin JL; Guipponi M; Bottani A; Antonarakis SE; Kosel MM; Fluss J; Paoloni-Giacobino A
J Hum Genet; 2018 Jul; 63(7):847-850. PubMed ID: 29717186
[TBL] [Abstract][Full Text] [Related]
9. A new family with an SLC9A6 mutation expanding the phenotypic spectrum of Christianson syndrome.
Masurel-Paulet A; Piton A; Chancenotte S; Redin C; Thauvin-Robinet C; Henrenger Y; Minot D; Creppy A; Ruffier-Bourdet M; Thevenon J; Kuentz P; Lehalle D; Curie A; Blanchard G; Ghosn E; Bonnet M; Archimbaud-Devilliers M; Huet F; Perret O; Philip N; Mandel JL; Faivre L
Am J Med Genet A; 2016 Aug; 170(8):2103-10. PubMed ID: 27256868
[TBL] [Abstract][Full Text] [Related]
10. The spectrum of ZEB2 mutations causing the Mowat-Wilson syndrome in Japanese populations.
Yamada Y; Nomura N; Yamada K; Matsuo M; Suzuki Y; Sameshima K; Kimura R; Yamamoto Y; Fukushi D; Fukuhara Y; Ishihara N; Nishi E; Imataka G; Suzumura H; Hamano S; Shimizu K; Iwakoshi M; Ohama K; Ohta A; Wakamoto H; Kajita M; Miura K; Yokochi K; Kosaki K; Kuroda T; Kosaki R; Hiraki Y; Saito K; Mizuno S; Kurosawa K; Okamoto N; Wakamatsu N
Am J Med Genet A; 2014 Aug; 164A(8):1899-908. PubMed ID: 24715670
[TBL] [Abstract][Full Text] [Related]
11. The DYRK1A gene is a cause of syndromic intellectual disability with severe microcephaly and epilepsy.
Courcet JB; Faivre L; Malzac P; Masurel-Paulet A; Lopez E; Callier P; Lambert L; Lemesle M; Thevenon J; Gigot N; Duplomb L; Ragon C; Marle N; Mosca-Boidron AL; Huet F; Philippe C; Moncla A; Thauvin-Robinet C
J Med Genet; 2012 Dec; 49(12):731-6. PubMed ID: 23099646
[TBL] [Abstract][Full Text] [Related]
12. Clinical spectrum of KIAA2022 pathogenic variants in males: Case report of two boys with KIAA2022 pathogenic variants and review of the literature.
Lorenzo M; Stolte-Dijkstra I; van Rheenen P; Smith RG; Scheers T; Walia JS
Am J Med Genet A; 2018 Jun; 176(6):1455-1462. PubMed ID: 29693785
[TBL] [Abstract][Full Text] [Related]
13. Genotype-phenotype correlation: Inheritance and variant-type infer pathogenicity in IQSEC2 gene.
Barrie ES; Cottrell CE; Gastier-Foster J; Hickey SE; Patel AD; Santoro SL; Alfaro MP
Eur J Med Genet; 2020 Mar; 63(3):103735. PubMed ID: 31415821
[TBL] [Abstract][Full Text] [Related]
14. A nonsense mutation of the sodium channel gene SCN2A in a patient with intractable epilepsy and mental decline.
Kamiya K; Kaneda M; Sugawara T; Mazaki E; Okamura N; Montal M; Makita N; Tanaka M; Fukushima K; Fujiwara T; Inoue Y; Yamakawa K
J Neurosci; 2004 Mar; 24(11):2690-8. PubMed ID: 15028761
[TBL] [Abstract][Full Text] [Related]
15. Neuroligin 2 nonsense variant associated with anxiety, autism, intellectual disability, hyperphagia, and obesity.
Parente DJ; Garriga C; Baskin B; Douglas G; Cho MT; Araujo GC; Shinawi M
Am J Med Genet A; 2017 Jan; 173(1):213-216. PubMed ID: 27865048
[TBL] [Abstract][Full Text] [Related]
16. A de novo CTNNB1 nonsense mutation associated with syndromic atypical hyperekplexia, microcephaly and intellectual disability: a case report.
Winczewska-Wiktor A; Badura-Stronka M; Monies-Nowicka A; Nowicki MM; Steinborn B; Latos-Bieleńska A; Monies D
BMC Neurol; 2016 Mar; 16():35. PubMed ID: 26968164
[TBL] [Abstract][Full Text] [Related]
17. Disruption of PHF21A causes syndromic intellectual disability with craniofacial anomalies, epilepsy, hypotonia, and neurobehavioral problems including autism.
Kim HG; Rosenfeld JA; Scott DA; Bénédicte G; Labonne JD; Brown J; McGuire M; Mahida S; Naidu S; Gutierrez J; Lesca G; des Portes V; Bruel AL; Sorlin A; Xia F; Capri Y; Muller E; McKnight D; Torti E; Rüschendorf F; Hummel O; Islam Z; Kolatkar PR; Layman LC; Ryu D; Kong IK; Madan-Khetarpal S; Kim CH
Mol Autism; 2019; 10():35. PubMed ID: 31649809
[TBL] [Abstract][Full Text] [Related]
18. A duplication of the whole KIAA2022 gene validates the gene role in the pathogenesis of intellectual disability and autism.
Charzewska A; Rzońca S; Janeczko M; Nawara M; Smyk M; Bal J; Hoffman-Zacharska D
Clin Genet; 2015 Sep; 88(3):297-9. PubMed ID: 25394356
[No Abstract] [Full Text] [Related]
19. De novo substitutions of TRPM3 cause intellectual disability and epilepsy.
Dyment DA; Terhal PA; Rustad CF; Tveten K; Griffith C; Jayakar P; Shinawi M; Ellingwood S; Smith R; van Gassen K; McWalter K; Innes AM; Lines MA
Eur J Hum Genet; 2019 Oct; 27(10):1611-1618. PubMed ID: 31278393
[TBL] [Abstract][Full Text] [Related]
20. 15q26.1 microdeletion encompassing only CHD2 and RGMA in two adults with moderate intellectual disability, epilepsy and truncal obesity.
Courage C; Houge G; Gallati S; Schjelderup J; Rieubland C
Eur J Med Genet; 2014 Sep; 57(9):520-3. PubMed ID: 24932903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
